Eli Lilly's tirzepatide, marketed under the brands Mounjaro for diabetes and Zepbound for weight management, is highly ...

Patients with systemic lupus erythematosus (SLE) and type 2 diabetes, with and without lupus nephritis (LN), had a lower risk ...

Excellus BlueCross BlueShield is pushing back against reports that it will no longer cover GLP-1 medications, saying drugs ...

Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. The secondary endpoints ...

Are we at the point where we need to be showing GLP-1 ads during a Disney movie? And why aren’t more speaking out about their ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon ...

Longevity doctors warn GLP-1 drugs may cost patients muscle, not just fat. ShapeScale’s 3D scans reveal the loss—and help ...

"However, in clinical trials, GLP-1 agonists reduce mortality by about 20%, and no single pharmaceutical treatment has ever ...

The FDA will decide on whether to approve the first oral formulation of a GLP-1 (once-daily semaglutide 25 mg) for chronic ...

GLP-1 drugs are booming, reshaping eating habits and challenging the confectionery industry. As users crave less sugar, ...

Of all the possible side effects that come with taking a GLP-1, losing your hair is perhaps one of the scariest. The good ...

Researchers from Duke University have found that, under certain conditions, cells in the pancreas can produce GLP-1 – the ...